January 19th- Luspatercept in Lower-Risk MDS- where do we stand CME Congresses . January 19th- Luspatercept in Lower-Risk MDS- where do we stand January 12th- “Genomically Smoldering” Myeloma Really Smoldering? CME Congresses . January 12th- “Genomically Smoldering” Myeloma Really Smoldering? January 5th- Linvoseltamab in relapsed refractory multiple myeloma: Durable Responses and Real-World Relevance CME Congresses . January 5th- Linvoseltamab in relapsed refractory multiple myeloma: Durable Responses and Real-World Relevance December 31st- Post-Transplant Cyclophosphamide in HLA-Matched Peripheral Blood Transplantation CME Congresses . December 31st- Post-Transplant Cyclophosphamide in HLA-Matched Peripheral Blood Transplantation December 29th- Dr. Richard Dillon and Dr. Jad Othman- Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML CME Congresses . December 29th- Dr. Richard Dillon and Dr. Jad Othman- Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML December 23rd- PRECISION-T: Are We Entering a New Era of GVHD Prophylaxis? CME Congresses . December 23rd- PRECISION-T: Are We Entering a New Era of GVHD Prophylaxis? December 19th- BEYOND the Horizon: Long-Term Luspatercept Data in non–transfusion-dependent β-thalassemia CME Congresses . December 19th- BEYOND the Horizon: Long-Term Luspatercept Data in non–transfusion-dependent β-thalassemia December 18th- ASH 2025 Highlight: Stem Cell Boost for CAR-T–Related Hematologic Toxicity in multiple myeloma: Real-World Evidence CME Congresses . December 18th- ASH 2025 Highlight: Stem Cell Boost for CAR-T–Related Hematologic Toxicity in multiple myeloma: Real-World Evidence December 16th- ASH 2025 Highlight- Menin Inhibitors AML Update CME Congresses . December 16th- ASH 2025 Highlight- Menin Inhibitors AML Update December 12th- ASH 2025 Spotlight: BRUIN CLL-313 Pirtobrutinib Moves to the Frontline CME Congresses . December 12th- ASH 2025 Spotlight: BRUIN CLL-313 Pirtobrutinib Moves to the Frontline Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27
